US Patent Issued to IREGENE THERAPEUTICS on Feb. 10 for "Application of TGF-B inhibitor in inducing neural stem cells and organoid formation" (Chinese Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,892, issued on Feb. 10, was assigned to IREGENE THERAPEUTICS LTD (Wuhan, China).

"Application of TGF-B inhibitor in inducing neural stem cells and organoid formation" was invented by Jun Wei (Wuhan, China), Meng Cai (Wuhan, China), Lumeng Niu (Wuhan, China), Jia Zhou (Wuhan, China) and Mengying Hou (Wuhan, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a new use of a TGF-Beta small molecule inhibitor in the field of neuroregeneration, which can be used for the in vitro regeneration and directed differentiation of various nerve cells and brain-like organs. By adding same to a set of basal media having clear chemical compositions. pl...